Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
ACADIA Pharmaceuticals (ACAD)
- 21.740
- -0.830-3.68%
Close Apr 10 16:00 ET
- 21.740
- 0.0000.00%
Post 20:01 ET
3.71BMarket Cap9.45P/E (TTM)
22.595High21.420Low849.31KVolume22.520Open22.570Prev Close18.44MTurnover0.67%Turnover Ratio9.45P/E (Static)170.49MShares28.35052wk High3.02P/B2.75BFloat Cap14.08052wk Low--Dividend TTM126.61MShs Float58.720Historical High--Div Yield TTM5.21%Range %0.650Historical Low21.715Avg Price1Lot Size
ACADIA Pharmaceuticals (ACAD) Key Financial Indicators
ACAD Earnings per Share (EPS)
According to the latest financial report of ACADIA Pharmaceuticals, the latest earnings per share (TTM) for the company is 1.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ACAD Free Cash Flow (FCF)
Interested in knowing about ACADIA Pharmaceuticals's free cash flow? The latest report shows it as 46.10M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ACAD Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ACADIA Pharmaceuticals shows that the company's current ratio is 3.83, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ACAD Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ACADIA Pharmaceuticals, the quick ratio is 3.49, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ACAD Return on Equity (ROE)
Want to learn more about the financial health of ACADIA Pharmaceuticals? The latest ROE figure is 25.51%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ACAD Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ACADIA Pharmaceuticals, the total asset return on investment (ROA) is 18.90%.
Currency: USD
Quarterly
Loading...
ACAD Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ACADIA Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 90.77%.
Currency: USD
Quarterly
Loading...
ACAD Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ACADIA Pharmaceuticals, the net profit margin is 96.33%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement,
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm